These Analysts Raise Their Forecasts On DocuSign After Better-Than-Expected Results

DocuSign Inc DOCU reported better-than-expected financial results for the third quarter Thursday.

DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analyst estimates of 87 cents per share, according to Benzinga Pro.

"Docusign delivered powerful new innovation for customers highlighted by new capabilities to its Intelligent Agreement Management ("IAM") platform," said Allan Thygesen, CEO of Docusign. "In Q3, early IAM momentum outpaced expectations, and we continued to drive improvement in our core business with strong revenue growth and operating profit."

DocuSign expects fourth-quarter revenue to be in the range of $758 million to $762 million versus estimates of $755.95 million. The company sees fourth-quarter billings in the range of $870 million to $880 million. DocuSign expects fiscal year 2025 revenue to be in the range of $2.959 billion to $2.963 billion versus estimates of $2.948 billion.

DocuSign shares climbed 28.1% to trade at $107.22 on Friday.

These analysts made changes to their price targets on DocuSign following earnings announcement.

• Baird analyst William Power maintained DocuSign with a Neutral and raised the price target from $59 to $100.
• JMP Securities analyst Patrick Walravens maintained the stock with a Market Outperform and boosted the price target from $108 to $124.
• Jefferies analyst Brent Thill maintained DocuSign with a Buy and increased the price target from $95 to $115.
• Piper Sandler analyst Rob Owens maintained DocuSign with a Neutral and raised the price target from $60 to $90.
• Wells Fargo analyst Michael Turrin maintained DocuSign with an Underweight and increased the price target from $50 to $70.
• RBC Capital analyst Rishi Jaluria maintained the stock with a Sector Perform and raised the price target from $57 to $90.
• UBS analyst Karl Keirstead maintained DocuSign with a Neutral and raised the price target from $60 to $100.
• Morgan Stanley analyst Josh Baer maintained the stock with an Equal-Weight and raised the price target from $62 to $97.

Considering buying DOCU stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings